Ren Shouzhong, Ren Chenhui, Zhao Yamei, Niu Haiyan, Xie Yiqiang
Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, International Joint Research Center of Human-machine Intelligent Collaborative for Tumor Precision Diagnosis and Treatment of Hainan Province, Hainan Provincial Key Laboratory of Research and Development on Tropical Herbs, School of Pharmacy, Hainan Medical University, Haikou, Hainan, China.
School of Life Sciences, Hainan University, Haikou, Hainan, China.
Front Pharmacol. 2024 Aug 13;15:1435166. doi: 10.3389/fphar.2024.1435166. eCollection 2024.
Stress-related gastric mucosal lesions (SGMLs) are the most common complication in critical care patients. Previous studies have demonstrated that herbal pair (HP), (HP P-C) has the anti-SGML effect. However, the underlying mechanism of HP P-C against SGML remains elusive. This study aimed to elucidate how HP P-C extracts exert their protective effects on SGML by examining the role of gut microbiota and metabolites. SD rats were pretreated with different doses of HP P-C extracts for 6 days, followed by inducing SGML with water-immersion restraint stress (WIRS). After a comprehensive evaluation of serum and gastric tissue indicators in rats, 16S rRNA sequencing and metabolomics analyses were conducted to assess the impact of HP P-C on the fecal microorganisms and metabolites and their correlation. Animal experiment suggested that pretreatment with HP P-C effectively reduced the gastric mucosal lesions, remarkably increased superoxide dismutase (SOD) activity in SGML model rats induced by WIRS. 16S rRNA sequencing analysis showed that HP P-C altered the composition of gut microbiota by raising the abundance of and . In addition, metabolomics data identified seventeen main differential metabolites related to WIRS-induced gastric mucosal injury, primarily involving in tyrosine metabolism and betalain biosynthesis. HP P-C was found to regulate tyrosine metabolism and betalain biosynthesis by down-regulating the tyramine, L-tyrosine and L-dopa and up -regulating the gentisic acid and dopaquinone. Taken together, this study indicated that HP P-C could effectively protect against WIRS-induced gastric mucosal lesions by modulating intestinal flora and metabolites.
应激相关胃黏膜损伤(SGMLs)是重症监护患者中最常见的并发症。以往研究表明,药对(HP),即芍药 - 甘草药对(HP P-C)具有抗SGML作用。然而,HP P-C抗SGML的潜在机制仍不清楚。本研究旨在通过研究肠道微生物群和代谢产物的作用,阐明HP P-C提取物如何对SGML发挥保护作用。将不同剂量的HP P-C提取物预处理SD大鼠6天,然后通过水浸束缚应激(WIRS)诱导SGML。在对大鼠血清和胃组织指标进行全面评估后,进行16S rRNA测序和代谢组学分析,以评估HP P-C对粪便微生物和代谢产物的影响及其相关性。动物实验表明,HP P-C预处理可有效减轻胃黏膜损伤,显著提高WIRS诱导的SGML模型大鼠的超氧化物歧化酶(SOD)活性。16S rRNA测序分析表明,HP P-C通过提高[具体菌属1]和[具体菌属2]的丰度改变了肠道微生物群的组成。此外,代谢组学数据确定了17种与WIRS诱导的胃黏膜损伤相关的主要差异代谢产物,主要涉及酪氨酸代谢和甜菜碱生物合成。发现HP P-C通过下调酪胺、L-酪氨酸和L-多巴以及上调龙胆酸和多巴醌来调节酪氨酸代谢和甜菜碱生物合成。综上所述,本研究表明,HP P-C可通过调节肠道菌群和代谢产物有效预防WIRS诱导的胃黏膜损伤。